Narcolepsy trials in Spain

In Spain 14 Also abroad 43

14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Not yet taking people in Spain
A Study to Investigate the Effects of Cleminorexton Compared with Placebo in the Treatment of Participants with Central Disorders of Hypersomnolence
Where
Alzira, Barcelona, Madrid, Vitoria
Age
18 years and over
People
168 worldwide
Run by
Centessa Pharmaceuticals UK Limited
See details and how to join2026-525961-37-00
Phase 2/3Taking people
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Where
Alzira, Barcelona, Madrid, Vitoria
Age
18 years to 70 years
People
786 worldwide
Run by
Alkermes, Inc.
See details and how to joinNCT06767683 · EU 2024-519822-18-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Where
Alzira, Barcelona, Madrid, Vitoria-Gasteiz
Age
18 years and over
People
116 worldwide
Run by
Alkermes Inc.
See details and how to join2025-524711-36-00
Phase 2Taking people
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Where
Madrid
Age
18 years to 70 years
People
88 worldwide
Run by
Takeda
See details and how to joinNCT06952699 · EU 2024-517711-70-01
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Where
Barcelona, Madrid, Vitoria-Gasteiz
Age
18 years to 70 years
People
150 worldwide
Run by
Alkermes, Inc.
See details and how to joinNCT07455383
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Where
Barcelona, Madrid
Age
18 years to 70 years
People
176 worldwide
Run by
Alkermes, Inc.
See details and how to joinNCT07502443
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Where
Alzira, Barcelona, Madrid, Vitoria
Age
18 years and over
People
115 worldwide
Run by
Alkermes Inc.
See details and how to join2025-523911-13-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Where
Alzira, Barcelona, Madrid, Vitoria
Age
18 years and over
People
132 worldwide
Run by
Alkermes Inc.
See details and how to join2025-523912-35-00
Phase 3Taking people
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Where
Alzira, Barcelona, Móstoles, Sevilla
Age
18 years and over
People
258 worldwide
Run by
Harmony Biosciences Management, Inc.
See details and how to joinNCT07675135 · EU 2025-523821-17-00
Phase 2Taking people
A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
Where
Barcelona, Madrid
Age
18 years to 70 years
People
92 worldwide
Run by
Takeda
See details and how to joinNCT07633301 · EU 2025-522587-33-00
Phase 2Taking people
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Where
Alzira, Barcelona, Donostia / San Sebastian, Madrid, Móstoles, Seville
Age
18 years and over
People
64 worldwide
Run by
Eisai Inc.
See details and how to joinNCT07493265
Phase 2Taking people
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Where
Madrid, Vitoria
Age
18 years to 65 years
People
248 worldwide
Run by
Centessa Pharmaceuticals (UK) Limited
See details and how to joinNCT06752668 · EU 2024-518929-15-00
Phase 2Taking people
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Where
Madrid, Vitoria
Age
18 years to 65 years
People
90 worldwide
Run by
Centessa Pharmaceuticals (UK) Limited
See details and how to joinNCT07096674 · EU 2025-522987-34-00
Phase 2/3Taking people
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Where
Alzira, Barcelona, Castello De La Plana, Madrid, Vitoria
Age
16 years to 70 years
People
500 worldwide
Run by
Takeda
See details and how to joinNCT05816382 · EU 2023-508462-15-00